Cancer Patient Awaits $1 Million Drug, Family Falls Victim to Online Scam
José Valentim Montanha, a 72-year-old retiree in Pirassununga, São Paulo, is awaiting a judicial decision to obtain a life-saving immunotherapy drug for his intestinal cancer. Diagnosed in 2024 and having undergone surgery the following year, his cancer has returned. Doctors prescribed pembrolizumab, a high-cost immunotherapy treatment, due to the toxicity of traditional chemotherapy. The complete treatment requires 70 doses and is estimated to cost over R$ 1.1 million (approximately $200,000 USD).
Montanha's care is currently managed by his son, Giovanni Montanha, and wife. The family initiated a lawsuit in January 2024, but their request was denied in the first instance in March. They have appealed to higher courts, with the case now assigned to a São Paulo judge. While awaiting the judicial outcome, Giovanni was targeted by an online scam. A woman offered four vials of the medication, requesting R$ 800 for shipping from Recife. After Giovanni paid, he was blocked by the scammer, highlighting how individuals exploit the suffering of others.
This situation reflects a broader trend in the region, with nearly 1,500 people in the area facing similar challenges in obtaining high-cost medications through legal means. Data from the National Council of Justice shows a significant number of lawsuits filed for medication provision. According to Octavio Augustus Cordeiro, coordinator of the Public Defender's Office in Rio Claro, the increase in judicial requests is due to greater public awareness of their rights and the development of new medical alternatives that public health systems struggle to keep pace with. However, the success rate of these lawsuits has decreased since September 2024, following a change in the Supreme Federal Court's understanding, which now imposes more rigorous requirements for medication approval.
This case exemplifies the growing challenge of healthcare access through judicial means, a phenomenon driven by the increasing cost of advanced medical treatments and the lag in public health system adaptation. While the legal route offers recourse, its effectiveness is being tempered by stricter judicial interpretations, requiring robust evidence of medical necessity and the inadequacy of existing public options. The family's experience with an online scam underscores the vulnerability of patients and their relatives navigating this complex and often desperate situation. Looking ahead, the tension between rapid pharmaceutical innovation, escalating treatment costs, and equitable public health provision will likely intensify, necessitating systemic reforms beyond judicial intervention to ensure timely and affordable access to essential medicines.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.